C&EN6 天
Configurational and Conformational Proclivity of an α-Cyanoacrylamide Derivative of Ibrutinib
Molecular Targets Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States ...